NEW YORK (GenomeWeb) – The National Cancer Institute has recently awarded a five-year, $4.1 million grant to MD Anderson Cancer Center researcher Michelle Hildebrandt to conduct a large-scale sequencing study to identify rare genomic variants associated with inherited ovarian cancer susceptibility.

Through genome-wide association studies, Hildebrandt and collaborators have identified 11 loci associated with ovarian cancer risk and plan to publish an additional six in the coming months, she wrote in her grant's abstract.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.